Compugen Stock Performance
| CGEN Stock | USD 1.54 0.05 3.14% |
On a scale of 0 to 100, Compugen holds a performance score of 4. The firm shows a Beta (market volatility) of 1.25, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Compugen will likely underperform. Please check Compugen's total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether Compugen's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Compugen are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Compugen displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Regenxbio Q1 Earnings and Revenues Lag Estimates | 05/12/2025 |
2 | Compugen Announces Leadership Transitions Effective September 2025 CGEN Stock News | 05/13/2025 |
3 | Compugen Q1 2025 Earnings Preview | 05/16/2025 |
4 | Compugen Posts Quarterly Earnings Results, Misses Expectations By 0.02 EPS | 05/19/2025 |
5 | Compugen Ltd Q1 2025 Earnings Call Highlights Strategic Advances Amid Revenue Decline | 05/20/2025 |
6 | Compugen to Present AIML Driven Predictive Computational Research at Upcoming International ... | 06/12/2025 |
7 | Graham Surges 7.4 percent Is This an Indication of Further Gains | 06/24/2025 |
| Begin Period Cash Flow | 14.3 M | |
| Total Cashflows From Investing Activities | -46.3 M |
Compugen Relative Risk vs. Return Landscape
If you would invest 139.00 in Compugen on April 21, 2025 and sell it today you would earn a total of 15.00 from holding Compugen or generate 10.79% return on investment over 90 days. Compugen is currently generating 0.2618% in daily expected returns and assumes 4.6116% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of stocks are less volatile than Compugen, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Compugen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Compugen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Compugen, and traders can use it to determine the average amount a Compugen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0568
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CGEN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.61 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Compugen is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Compugen by adding it to a well-diversified portfolio.
Compugen Fundamentals Growth
Compugen Stock prices reflect investors' perceptions of the future prospects and financial health of Compugen, and Compugen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Compugen Stock performance.
| Return On Equity | -0.24 | ||||
| Return On Asset | -0.0807 | ||||
| Profit Margin | (0.51) % | ||||
| Operating Margin | (3.68) % | ||||
| Current Valuation | 47.49 M | ||||
| Shares Outstanding | 93.51 M | ||||
| Price To Earning | (4.86) X | ||||
| Price To Book | 2.60 X | ||||
| Price To Sales | 5.22 X | ||||
| Revenue | 27.86 M | ||||
| Gross Profit | 19.36 M | ||||
| EBITDA | (14.4 M) | ||||
| Net Income | (14.23 M) | ||||
| Cash And Equivalents | 88.21 M | ||||
| Cash Per Share | 1.02 X | ||||
| Total Debt | 2.91 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 6.16 X | ||||
| Book Value Per Share | 0.62 X | ||||
| Cash Flow From Operations | 49.6 M | ||||
| Earnings Per Share | (0.16) X | ||||
| Market Capitalization | 144.01 M | ||||
| Total Asset | 115 M | ||||
| Retained Earnings | (488.76 M) | ||||
| Working Capital | 85.84 M | ||||
| Current Asset | 53.09 M | ||||
| Current Liabilities | 8.38 M | ||||
About Compugen Performance
By examining Compugen's fundamental ratios, stakeholders can obtain critical insights into Compugen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Compugen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -31.3 K | -32.8 K | |
| Return On Tangible Assets | (0.12) | (0.13) | |
| Return On Capital Employed | (0.16) | (0.16) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (0.26) | (0.27) |
Things to note about Compugen performance evaluation
Checking the ongoing alerts about Compugen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Compugen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Compugen may become a speculative penny stock | |
| Compugen had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 27.86 M. Net Loss for the year was (14.23 M) with profit before overhead, payroll, taxes, and interest of 19.36 M. | |
| Compugen has a strong financial position based on the latest SEC filings | |
| Latest headline from zacks.com: Graham Surges 7.4 percent Is This an Indication of Further Gains |
- Analyzing Compugen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Compugen's stock is overvalued or undervalued compared to its peers.
- Examining Compugen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Compugen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Compugen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Compugen's stock. These opinions can provide insight into Compugen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.16) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.